Which has the lower trailing P/E, PFE or STZ?

STZ has the lower trailing P/E: PFE trades at 36.63 and STZ at 11.93. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, PFE or STZ?

Over the past five years, PFE grew revenue faster — PFE at a 6.29% CAGR versus STZ at 0.86%.

Does PFE or STZ pay a bigger dividend?

PFE yields 6.20% and STZ yields 3.35% based on trailing dividends and the latest price.

Is PFE or STZ more profitable?

STZ runs the higher net margin — PFE at 6.81% versus STZ at 20.14%.

How have PFE and STZ total returns compared?

Over the past 10 years, PFE delivered 3.15% and STZ delivered -1.19% annualized total return. Past performance doesn't predict future results.

Pfizer Inc. (PFE) vs Constellation Brands, Inc. (STZ)

A side-by-side comparison of Pfizer Inc. and Constellation Brands, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

Different business models: PFE is classified in Healthcare; STZ is classified in Consumer Defensive. Margin, capital intensity, and valuation differences should be interpreted in that sector context.

PFE

Pfizer Inc.

$157.99B

$27.72HealthcareDelayed quote: Sep 14, 2026, 4:01 PM EDT

STZ

Constellation Brands, Inc.

$21.35B

$125.00Consumer DefensiveDelayed quote: Sep 14, 2026, 4:00 PM EDT

Total return — PFE vs STZ

growth of $100 · dividends reinvested · last 10y

PFE +37.0% (+3.2%/yr)STZ -12.5% (-1.3%/yr)PFE compounded faster over this window

PFE STZ

PFE vs STZ: by the numbers

•PFE is the larger company ($157.99B vs $21.35B market cap).
•STZ trades at the lower trailing earnings multiple (11.93 vs 36.63 P/E), one valuation lens rather than an overall verdict.
•STZ converts more revenue to profit (20.14% vs 6.81% net margin).
•PFE grew revenue faster over the past five years (6.29% vs 0.86% CAGR).
•PFE pays the higher dividend yield (6.20% vs 3.35%).

Metrics side by side

Valuation

Metric	PFE	STZ
P/E ratio	36.63	11.93
Forward P/E	9.32	10.59
P/S ratio	2.48	2.36
P/B ratio	1.85	2.59
EV / EBITDA	10.15	9.57
FCF yield	6.95%	8.59%

Profitability

Metric	PFE	STZ
Gross margin	71.32%	52.62%
Operating margin	25.08%	32.14%
Net margin	6.81%	20.14%
ROE	5.09%	22.10%
ROIC	9.33%	10.85%

Dividends

Metric	PFE	STZ
Dividend yield	6.20%	3.35%
Payout ratio	227.27%	39.12%

Growth (annualized)

Metric	PFE	STZ
Revenue CAGR (5Y)	6.29%	0.86%
EPS CAGR (5Y)	-3.78%	-1.59%
FCF CAGR (5Y)	-3.11%	-1.73%
Total return CAGR (5Y)	-4.53%	-8.87%

Frequently asked

Which has the lower trailing P/E, PFE or STZ?: STZ has the lower trailing P/E: PFE trades at 36.63 and STZ at 11.93. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, PFE or STZ?: Over the past five years, PFE grew revenue faster — PFE at a 6.29% CAGR versus STZ at 0.86%.
Does PFE or STZ pay a bigger dividend?: PFE yields 6.20% and STZ yields 3.35% based on trailing dividends and the latest price.
Is PFE or STZ more profitable?: STZ runs the higher net margin — PFE at 6.81% versus STZ at 20.14%.
How have PFE and STZ total returns compared?: Over the past 10 years, PFE delivered 3.15% and STZ delivered -1.19% annualized total return. Past performance doesn't predict future results.

Go deeper

Full PFE analysis Full STZ analysis Interactive comparison tool

Dig into the metrics

Pfizer P/E ratio Constellation Brands P/E ratio Pfizer dividend yield Constellation Brands dividend yield Pfizer ROE Constellation Brands ROE Pfizer operating margin Constellation Brands operating margin Pfizer revenue growth Constellation Brands revenue growth Pfizer free cash flow Constellation Brands free cash flow

Pfizer & Constellation Brands appear in these rankings

Highest Dividend Yield Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.